| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.094 | 0.04 |